Avoro Capital Advisors LLC Diversified Active

Location: New York, NY

CIK: 0001633313 · Show all filings

Period: Q1 2015 (← Previous) (Next →)

Filing Date: May 15, 2015

Total Value: $261M (98.8% shares, 1.2% debt)

Holdings (33)

FOLD AMICUS THERAPEUTICS INC 17.6%

Value $45.82M Shares 4,211,399 Est. Cost $7.51 Unrealized +17.4%

— LION BIOTECHNOLOGIES INC 10.0%

Value $26.04M Shares 2,149,907 Est. Cost $12.11 Unrealized —

SRNE SORRENTO THERAPEUTICS INC 9.8%

Value $25.59M Shares 2,214,043 Est. Cost $8.90 Unrealized +30.0%

— CELGENE CORP. 6.6%

Value $17.15M Shares 148,800 Est. Cost $115.28 Unrealized —

— PERNIX THERAPEUTICS HOLDINGS 5.7%

Value $14.91M Shares 1,395,167 Est. Cost $9.63 Unrealized —

— BELLICUM PHARMACEUTICALS INC 4.2%

Value $11.01M Shares 475,015 Est. Cost $23.11 Unrealized —

— AGENUS - INC 4.0%

Value $10.51M Shares 2,047,971 Est. Cost $3.97 Unrealized —

EBS EMERGENT BIOSOLUTIONS INC 3.6%

Value $9.509M Shares 330,635 Est. Cost $23.83 Unrealized +20.3%

— MIRATI THERAPEUTICS INC. 3.6%

Value $9.408M Shares 320,867 Est. Cost $29.32 Unrealized —

— LA JOLLA PHARMACEUTICAL CO. 3.2%

Value $8.445M Shares 461,499 Est. Cost $18.38 Unrealized —

— TARO PHARMACEUTICAL INDUS 2.9%

Value $7.587M Shares 53,800 Est. Cost $148.19 Unrealized —

— ONCOTHYREON INC 2.8%

Value $7.321M Shares 4,491,636 Est. Cost $1.81 Unrealized —

— RECEPTOS INC 2.8%

Value $7.255M Shares 44,000 Est. Cost $122.51 Unrealized —

— STEMLINE THERAPEUTICS - INC 2.6%

Value $6.873M Shares 475,000 Est. Cost $14.47 Unrealized —

— IGI LABORATORIES INC 2.3%

Value $5.883M Shares 720,908 Est. Cost $8.57 Unrealized —

QURE UNIQURE N V 2.1%

Value $5.507M Shares 226,456 Est. Cost $21.81 Unrealized 0.0%

— TONIX PHARMACEUTICALS HLDG 1.8%

Value $4.773M Shares 755,300 Est. Cost $6.32 Unrealized —

VCEL VERICEL CORP. 1.5%

Value $3.918M Shares 1,058,820 Est. Cost $2.85 Unrealized +19.7%

— FLAMEL TECHNOLOGIES 1.5%

Value $3.878M Shares 215,705 Est. Cost $17.13 Unrealized —

SGMO SANGAMO BIOSCIENCES INC 1.5%

Value $3.829M Shares 244,199 Est. Cost $15.47 Unrealized 0.0%

— TRILLIUM THERAPEUTICS INC 1.2%

Value $3.234M Shares 160,697 Est. Cost $20.12 Unrealized —

— EXELIXIS INC EXEL 20190815 4.250000% 1.2%

Value $3.234M Shares 4,250,000 Est. Cost $0.56 Unrealized —

— CHEMOCENTRYX - INC 0.9%

Value $2.443M Shares 323,607 Est. Cost $7.55 Unrealized —

— THERAPEUTICS MD INC 0.9%

Value $2.372M Shares 392,000 Est. Cost $6.05 Unrealized —

— CORONADO BIOSCIENCES INC 0.9%

Value $2.31M Shares 600,000 Est. Cost $3.85 Unrealized —

— TROVAGENE INC 0.8%

Value $2.205M Shares 323,728 Est. Cost $6.81 Unrealized —

— IGNYTA INC. 0.8%

Value $1.998M Shares 200,772 Est. Cost $6.85 Unrealized —

— INNOCOLL AG 0.6%

Value $1.689M Shares 225,000 Est. Cost $5.93 Unrealized —

— HEAT BIOLOGICS INC 0.6%

Value $1.654M Shares 260,000 Est. Cost $6.36 Unrealized —

— BIOLASE INC 0.5%

Value $1.394M Shares 690,000 Est. Cost $2.63 Unrealized —

— TARGACEPT INC 0.5%

Value $1.385M Shares 466,297 Est. Cost $2.97 Unrealized —

CLLS CELLECTIS 0.4%

Value $1.037M Shares 30,000 Est. Cost $34.57 Unrealized —

— ALIMERA SCIENCES INC 0.2%

Value $408K Shares 81,372 Est. Cost $5.02 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
FOLD	AMICUS THERAPEUTICS INC	4,211,399	$45.82M	17.6%	$7.51	+17.4%	Common	03152W109
—	LION BIOTECHNOLOGIES INC	2,149,907	$26.04M	10.0%	$12.11	—	Common	53619R102
SRNE	SORRENTO THERAPEUTICS INC	2,214,043	$25.59M	9.8%	$8.90	+30.0%	Common	83587F202
—	CELGENE CORP.	148,800	$17.15M	6.6%	$115.28	—	Common	151020904
—	PERNIX THERAPEUTICS HOLDINGS	1,395,167	$14.91M	5.7%	$9.63	—	Common	71426V108
—	BELLICUM PHARMACEUTICALS INC	475,015	$11.01M	4.2%	$23.11	—	Common	079481107
—	AGENUS - INC	2,047,971	$10.51M	4.0%	$3.97	—	Common	00847G705
EBS	EMERGENT BIOSOLUTIONS INC	330,635	$9.509M	3.6%	$23.83	+20.3%	Common	29089Q105
—	MIRATI THERAPEUTICS INC.	320,867	$9.408M	3.6%	$29.32	—	Common	60468T105
—	LA JOLLA PHARMACEUTICAL CO.	461,499	$8.445M	3.2%	$18.38	—	Common	503459604
—	TARO PHARMACEUTICAL INDUS	53,800	$7.587M	2.9%	$148.19	—	Shares	M8737E108
—	ONCOTHYREON INC	4,491,636	$7.321M	2.8%	$1.81	—	Common	682324108
—	RECEPTOS INC	44,000	$7.255M	2.8%	$122.51	—	Common	756207106
—	STEMLINE THERAPEUTICS - INC	475,000	$6.873M	2.6%	$14.47	—	Common	85858C107
—	IGI LABORATORIES INC	720,908	$5.883M	2.3%	$8.57	—	Common	449575109
QURE	UNIQURE N V	226,456	$5.507M	2.1%	$21.81	0.0%	Common	N90064101
—	TONIX PHARMACEUTICALS HLDG	755,300	$4.773M	1.8%	$6.32	—	Common	890260201
VCEL	VERICEL CORP.	1,058,820	$3.918M	1.5%	$2.85	+19.7%	Common	92346J108
—	FLAMEL TECHNOLOGIES	215,705	$3.878M	1.5%	$17.13	—	Sponsored ADR	338488109
SGMO	SANGAMO BIOSCIENCES INC	244,199	$3.829M	1.5%	$15.47	0.0%	Common	800677106
—	TRILLIUM THERAPEUTICS INC	160,697	$3.234M	1.2%	$20.12	—	Common	89620X506
—	EXELIXIS INC EXEL 20190815 4.250000%	4,250,000	$3.234M	1.2%	$0.56	—	Notes	30161QAC8
—	CHEMOCENTRYX - INC	323,607	$2.443M	0.9%	$7.55	—	Common	16383L106
—	THERAPEUTICS MD INC	392,000	$2.372M	0.9%	$6.05	—	Common	88338N107
—	CORONADO BIOSCIENCES INC	600,000	$2.31M	0.9%	$3.85	—	Common	21976U109
—	TROVAGENE INC	323,728	$2.205M	0.8%	$6.81	—	Common	897238309
—	IGNYTA INC.	200,772	$1.998M	0.8%	$6.85	—	Common	451731103
—	INNOCOLL AG	225,000	$1.689M	0.6%	$5.93	—	Sponsored ADR	45780Q103
—	HEAT BIOLOGICS INC	260,000	$1.654M	0.6%	$6.36	—	Common	42237K102
—	BIOLASE INC	690,000	$1.394M	0.5%	$2.63	—	Common	090911108
—	TARGACEPT INC	466,297	$1.385M	0.5%	$2.97	—	Common	87611R306
CLLS	CELLECTIS	30,000	$1.037M	0.4%	$34.57	—	Sponsored ADS	15117K103
—	ALIMERA SCIENCES INC	81,372	$408K	0.2%	$5.02	—	Common	016259103